معرفی
James Broach is a Distinguished Professor and Interim Chair of the Department of Molecular and Precision Medicine at Penn State College of Medicine. He also serves as Professor in the Department of Otolaryngology - Head and Neck Surgery, Director of the Institute for Personalized Medicine, and Member of the Penn State Cancer Institute's Next-Generation Therapies program. His leadership spans multiple departments and research initiatives focused on genomic medicine and personalized healthcare approaches.
Dr. Broach's research interests center on molecular biology and genetics, with particular expertise in yeast Saccharomyces as a model system for studying cellular processes. His laboratory has extensively investigated cell signaling pathways including Ras/protein kinase A and Target of Rapamycin Complex, examining how cells perceive nutritional states and respond metabolically and transcriptionally. More recently, his work has expanded to cellular stress responses using single-cell imaging and genomic sequencing techniques, revealing how genetically identical cells develop heterogeneous responses to environmental stresses. His research has significant implications for understanding population-level survival strategies in uncertain conditions.
Through the Institute for Personalized Medicine, Dr. Broach has applied genomic tools to disease onset and treatment across multiple conditions including various cancers, ALS, multiple sclerosis, inflammatory bowel disease, epilepsy, and osteoporosis. His recent publications demonstrate a strong focus on precision medicine applications, cancer biology, and genomic data frameworks that integrate clinical information with genetic profiling.
Among his notable scientific achievements are two Career Citation Milestone Awards: the M (1000) Club award in 2017 and the D (500) Club award in 2020, recognizing his substantial research impact. His h-index of 72 with over 18,259 citations reflects significant scholarly influence in his fields.
Dr. Broach has secured substantial research funding through multiple grants from prestigious organizations including the National Institutes of Health, National Science Foundation, and National Center for Research Resources. His current projects include the Penn State Biomedical Big Data to Knowledge (B2D2K) Training Program and continued research on Ras and TOR Signaling in Yeast. He collaborates extensively with clinicians at the Milton S. Hershey Medical Center to identify patient cohorts with distinctive disease presentations or treatment responses.
The Institute for Personalized Medicine, which Dr. Broach directs, comprises a comprehensive infrastructure including a biorepository for patient samples, a genomics core for advanced sequencing, and a bioinformatics core for correlating genomic data with clinical outcomes. This integrated approach enables groundbreaking research in precision medicine applications across multiple disease areas.
